Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/13/23 20:49 | 12/11/23 | FLGT | Health | Health | Medical Laboratories | Xie Jian | CA | O | P,COO | 7 | S | -872 | 28.19 | 0 | -31 | 648 | D | |||||||||||||||
12/6/23 17:54 | 12/4/23 | FLGT | Health | Health | Medical Laboratories | Kim Paul | CA | O | CFO,Trea | 7 | S | -631 | 33.19 | 0 | -19 | 230 | D | |||||||||||||||
12/6/23 17:47 | 12/4/23 | FLGT | Health | Health | Medical Laboratories | Gao Hanlin | CA | O | Chief Sc | 5 | S | -136 | 32.76 | 0 | -4 | 0 | 915 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |